132 related articles for article (PubMed ID: 14647534)
1. RWJ-58259: a selective antagonist of protease activated receptor-1.
Damiano BP; Derian CK; Maryanoff BE; Zhang HC; Gordon PA
Cardiovasc Drug Rev; 2003; 21(4):313-26. PubMed ID: 14647534
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
[TBL] [Abstract][Full Text] [Related]
3. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats.
Andrade-Gordon P; Derian CK; Maryanoff BE; Zhang HC; Addo MF; Cheung Wm ; Damiano BP; D'Andrea MR; Darrow AL; de Garavilla L; Eckardt AJ; Giardino EC; Haertlein BJ; McComsey DF
J Pharmacol Exp Ther; 2001 Jul; 298(1):34-42. PubMed ID: 11408522
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1).
Maryanoff BE; Zhang HC; Andrade-Gordon P; Derian CK
Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):13-36. PubMed ID: 15317288
[TBL] [Abstract][Full Text] [Related]
5. Identification of an active metabolite of PAR-1 antagonist RWJ-58259 and synthesis of analogues to enhance its metabolic stability.
Robinson E; Knight E; Smoktunowicz N; Chambers RC; Inglis GG; Chudasama V; Caddick S
Org Biomol Chem; 2016 Mar; 14(12):3198-201. PubMed ID: 26927018
[TBL] [Abstract][Full Text] [Related]
6. Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin.
Fang M; Kovács KJ; Fisher LL; Larson AA
J Physiol; 2003 Jun; 549(Pt 3):903-17. PubMed ID: 12717003
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.
Ahn HS; Foster C; Boykow G; Stamford A; Manna M; Graziano M
Biochem Pharmacol; 2000 Nov; 60(10):1425-34. PubMed ID: 11020444
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor.
Andrade-Gordon P; Maryanoff BE; Derian CK; Zhang HC; Addo MF; Darrow AL; Eckardt AJ; Hoekstra WJ; McComsey DF; Oksenberg D; Reynolds EE; Santulli RJ; Scarborough RM; Smith CE; White KB
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12257-62. PubMed ID: 10535908
[TBL] [Abstract][Full Text] [Related]
10. Non-peptidic small-molecule antagonists of the human platelet thrombin receptor PAR-1.
Selnick HG; Barrow JC; Nantermet PG; Connolly TM
Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):47-59. PubMed ID: 15317290
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-1 negatively regulates proliferation of neural stem/progenitor cells derived from the hippocampal dentate gyrus of the adult mouse.
Tanaka M; Yoneyama M; Shiba T; Yamaguchi T; Ogita K
J Pharmacol Sci; 2016 Jul; 131(3):162-71. PubMed ID: 27426918
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonist.
Damiano BP; Mitchell JA; Giardino E; Corcoran T; Haertlein BJ; de Garavilla L; Kauffman JA; Hoekstra WJ; Maryanoff BE; Andrade-Gordon P
Thromb Res; 2001 Oct; 104(2):113-26. PubMed ID: 11672755
[TBL] [Abstract][Full Text] [Related]
13. Indications for the presence of an atypical protease-activated receptor on rat platelets.
Ruef J; Kacharava A; Pohl J; Bode C; Runge MS
Ann Hematol; 2000 Nov; 79(11):604-11. PubMed ID: 11131919
[TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonist.
Hawes BE; Zhai Y; Hesk D; Wirth M; Wei H; Chintala M; Seiffert D
Eur J Pharmacol; 2015 Sep; 762():221-8. PubMed ID: 26022529
[TBL] [Abstract][Full Text] [Related]
15. Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis.
Zania P; Kritikou S; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
J Pharmacol Exp Ther; 2006 Jul; 318(1):246-54. PubMed ID: 16595737
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor.
Giardino EC; Costanzo MJ; Kauffman JA; Li QS; Maryanoff BE; Andrade-Gordon P
Thromb Res; 2000 Apr; 98(1):83-93. PubMed ID: 10706936
[TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of a novel series of thrombin receptor (par-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates.
Zhang HC; Derian CK; Andrade-Gordon P; Hoekstra WJ; McComsey DF; White KB; Poulter BL; Addo MF; Cheung WM; Damiano BP; Oksenberg D; Reynolds EE; Pandey A; Scarborough RM; Maryanoff BE
J Med Chem; 2001 Mar; 44(7):1021-4. PubMed ID: 11297447
[No Abstract] [Full Text] [Related]
18. PAR-1-dependent and PAR-independent pro-inflammatory signaling in human lung fibroblasts exposed to thrombin.
Ortiz-Stern A; Deng X; Smoktunowicz N; Mercer PF; Chambers RC
J Cell Physiol; 2012 Nov; 227(11):3575-84. PubMed ID: 22278285
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
Chieng-Yane P; Bocquet A; Létienne R; Bourbon T; Sablayrolles S; Perez M; Hatem SN; Lompré AM; Le Grand B; David-Dufilho M
J Pharmacol Exp Ther; 2011 Mar; 336(3):643-51. PubMed ID: 21139058
[TBL] [Abstract][Full Text] [Related]
20. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
